Literature DB >> 26290399

A review of the clinical experience in pulsed dose rate brachytherapy.

Brian V Balgobind1, Kees Koedooder1, Diego Ordoñez Zúñiga1, Raquel Dávila Fajardo1, Coen R N Rasch1, Bradley R Pieters1.   

Abstract

Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose.

Entities:  

Mesh：

Year:  2015        PMID： 26290399      PMCID： PMC4743453          DOI： 10.1259/bjr.20150310

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  92 in total

1.  Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.

Authors:  Adeline Petit; Anne Floquet; Olivier Lasbareilles; Eberhard Stoeckle; Antony Chemin; Michèle Kind; Frédéric Guyon; Véronique Brouste; Jacques Pigneux; Laurence Thomas
Journal:  Brachytherapy       Date:  2013-07-20       Impact factor: 2.362

2.  Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.

Authors:  C C E Koning; L E C M Blank; C Koedooder; R M van Os; M van de Kar; E Jansen; J J Battermann; M Beijert; C Gernaat; K A M van Herpen; C Hoekstra; S Horenblas; J J Jobsen; A D G Krol; M L M Lybeert; I E W van Onna; R C M Pelger; P Poortmans; F J Pos; E van der Steen-Banasik; A Slot; A Visser; B R Pieters
Journal:  Ann Oncol       Date:  2012-06-19       Impact factor: 32.976

3.  Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.

Authors:  Claire Charra-Brunaud; Valentin Harter; Martine Delannes; Christine Haie-Meder; Philippe Quetin; Christine Kerr; Bernard Castelain; Laurence Thomas; Didier Peiffert
Journal:  Radiother Oncol       Date:  2012-05-25       Impact factor: 6.280

4.  Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.

Authors:  Daniela Kauer-Dorner; Richard Pötter; Alexandra Resch; Leonore Handl-Zeller; Kathrin Kirchheiner; Katja Meyer-Schell; Wolfgang Dörr
Journal:  Radiother Oncol       Date:  2011-09-08       Impact factor: 6.280

5.  Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.

Authors:  Vratislav Strnad; Michael Lotter; Stephan Kreppner; Rainer Fietkau
Journal:  Brachytherapy       Date:  2013-11-06       Impact factor: 2.362

6.  Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.

Authors:  Floris J Pos; Simon Horenblas; Joos Lebesque; Luc Moonen; Christoph Schneider; Peter Sminia; Harry Bartelink
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

7.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

8.  Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.

Authors:  Sabrina Boyrie; Claire Charra-Brunaud; Valentin Harter; Anne Ducassou; Youlia Kirova; Isabelle Barillot; Claude Krzisch; Philippe Lang; Marie-Hélène Baron; Xavier Montbarbon; Martine Delannes; Didier Peiffert
Journal:  Brachytherapy       Date:  2014 Jul-Aug       Impact factor: 2.362

Review 9.  Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy - a literature review.

Authors:  Antonio Cássio Assis Pellizzon
Journal:  J Contemp Brachytherapy       Date:  2014-10-06

10.  Interstitial brachytherapy for bladder cancer with the aid of laparoscopy.

Authors:  Annemieke Nap-van Klinken; Saskia J E A Bus; Theodorus G Janssen; Marion P R Van Gellekom; Geert Smits; Elzbieta Van der Steen-Banasik
Journal:  J Contemp Brachytherapy       Date:  2014-09-23
View more
  4 in total

1.  The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer.

Authors:  Jiheon Song; Najlaa Alyamani; Gaurav Bhattacharya; Tien Le; Choan E; Rajiv Samant
Journal:  Adv Radiat Oncol       Date:  2020-02-28

2.  Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities.

Authors:  Uma Goyal; Michael K Cheung; Justin Suszko; Brady Laughlin; Yongbok Kim; Jeanette Askam; Hina Arif-Tiwari; Benjamin Slane; John Gordon; Baldassare Stea
Journal:  J Contemp Brachytherapy       Date:  2021-10-06

Review 3.  Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review.

Authors:  Fariba Tohidinezhad; Yves Willems; Maaike Berbee; Evert Van Limbergen; Frank Verhaegen; Andre Dekker; Alberto Traverso
Journal:  J Contemp Brachytherapy       Date:  2022-08-31

4.  High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.

Authors:  Andrea Vavassori; Giulia Riva; Ruggero Spoto; Roberta Lazzari; Cristiana Fodor; Samantha Dicuonzo; Claudia Maria Francia; Matteo Augugliaro; Giuseppe Facondo; Raffaella Cambria; Stefania Comi; Federica Cattani; Francesca Botta; Vincenzo Bagnardi; Stefania Rizzo; Nicoletta Colombo; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2019-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.